AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19221150
Drug: First-line chemotherapy
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: First-line chemotherapy with prophylactic cranial irradiation
Trial: 19221150
Drug: First-line chemotherapy
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: First-line chemotherapy without prophylactic cranial irradiation
Trial: 9174558
Drug: Heparin (5000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (5000 IU bd)
Trial: 9174558
Drug: Heparin (12,500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (12,500 IU bd)
Trial: 8198237
Drug: Open challenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open challenge with food additives (coloring agents, preservatives, citric acid, flavoring agents) using carbonated lemonade; two doses: low dose and 10-fold higher dose.
Trial: 8198237
Drug: Double-blind challenge
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-blind challenge with food additives (preservatives, coloring agents, citric acid) using gelatin capsules.
Trial: 29609646
Drug: Stereotactic body-radiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stereotactic body-radiotherapy (SBRT) boost dose of 18 Gy
Trial: 29609646
Drug: Stereotactic body-radiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stereotactic body-radiotherapy (SBRT) boost dose of 21 Gy
Trial: 29609646
Drug: Stereotactic body-radiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stereotactic body-radiotherapy (SBRT) boost (both doses)
Trial: 9120932
Drug: Oral antiandrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antiandrogen (nilutamide)
Trial: 27586458
Drug: Community Health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community Health Agents (WAJA)
Trial: 22055330
Drug: Selective serotonin
RxNorm normalized name: Selective serotonin (5HT1) agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective serotonin reuptake inhibitors (SSRIs) for 8 weeks
Trial: 22055330
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment plus SSRIs
Trial: 18380940
Drug: Vaccination (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccination (twice before surgery or conservative treatment)
Trial: 16034289
Drug: Shelter-based intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shelter-based intervention including intensive outreach by a psychiatric social worker and availability of weekly psychiatrist visits
Trial: 12464463
Drug: 14‐mg nicotine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14‐mg nicotine patch
Trial: 10234601
Drug: Nonprescription ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Nonprescription ibuprofen (800 to 1200 mg/day for 1 to 10 days)
Trial: 10234601
Drug: Nonprescription ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Nonprescription ibuprofen
Trial: 7795325
Drug: Counseling format
RxNorm normalized name: formate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Counseling format A (informed antibiotics are safe)
Trial: 7795325
Drug: Counseling format
RxNorm normalized name: formate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Counseling format B (informed antibiotics are safe and about theoretical risk of diarrhea)
Trial: 1674104
Drug: Beta-adrenergic-antagonist treatment
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-adrenergic-antagonist treatment (propranolol in 203 patients and nadolol in 83 patients)
Trial: 6795245
Drug: Haloperidol (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (mean dose, 3.1 mg/day)
Trial: 6795245
Drug: Lithium carbonate
RxNorm normalized name: Lithium Carbonate
DrugBank: Lithium carbonate (DB14509)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lithium carbonate (mean dose, 1150 mg/day)
Trial: 28661822
Drug: Family-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family-based treatment for substance abuse disorder
Trial: 25374101
Drug: 40 IU
RxNorm normalized name: Oxytocin 40 IU/1 ML Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 IU insulin detemir
Trial: 21340475
Drug: Melatonin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin treatment (mean dose 2.69 mg, mean duration 3.1 years)
Trial: 10907116
Drug: Fasting split
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasting split proinsulin and 30-min insulin concentrations
Trial: 10907116
Drug: Fasting, split
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasting, split proinsulin and 30-min insulin concentrations
Trial: 10907116
Drug: Insulin concentrations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin concentrations
Trial: 25981810
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg sonidegib
Trial: 25981810
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg sonidegib
Trial: 24173657
Drug: Venlafaxine hydrochloride
RxNorm normalized name: Venlafaxine Hydrochloride
DrugBank: Venlafaxine (DB00285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Venlafaxine hydrochloride extended release (up to 300 mg)
Trial: 24173657
Drug: Fluoxetine hydrochloride
RxNorm normalized name: Fluoxetine Hydrochloride
DrugBank: Fluoxetine (DB00472)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluoxetine hydrochloride (up to 80 mg)
Trial: 17180156
Drug: Intra‐dialytic parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra‐dialytic parenteral nutrition (IDPN) with exercise
Trial: 17180156
Drug: Intra‐dialytic parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra‐dialytic parenteral nutrition (IDPN) alone
Trial: 11997706
Drug: Dopamine D2-class
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine D2-class receptor antagonist sulpiride
Trial: 29519133
Drug: Fentanyl-soaked biodegradable
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl-soaked biodegradable synthetic polyurethane foams packing (50 mcg)
Trial: 21317777
Drug: Preincision intravenous
RxNorm normalized name: Precise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preincision intravenous normal saline and direct infiltration of dexmedetomidine (1 μg/kg) to the surgical wounds at the end of the surgery (Group P)
Trial: 21317777
Drug: Preincision intravenous
RxNorm normalized name: Precise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preincision intravenous dexmedetomidine (1 mcg/kg) and direct infiltration of normal saline to the surgical wounds at the end of the surgery (Group D)
Trial: 19571773
Drug: Oral fluid
RxNorm normalized name: cascara sagrada ORAL FLUID EXTRACT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fluid analysis
Trial: 16179403
Drug: After 35-45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: After 35-45 min of local cooling at BT + L-NAME sites
Trial: 15750259
Drug: Valsartan (an
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan (an angiotensin II receptor blocker)
Trial: 11308252
Drug: Clodronate (1.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clodronate (1.6 g daily orally) for 3 years
Trial: 11308252
Drug: Antioestrogen therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioestrogen therapy (tamoxifen 20 mg or toremifene 60 mg daily) for 3 years
Trial: 9329386
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg MK-677
Trial: 9329386
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg MK-677
Trial: 3142943
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg rt-PA intravenously over 3 h
Trial: 31651213
Drug: Integrated Psychological
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrated Psychological Therapy (IPT) + Emotional Management Training (EMT)
Trial: 25497473
Drug: bupropion-sustained-release+escitalopram
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupropion-sustained-release+escitalopram
Trial: 25497473
Drug: venlafaxine-extended-release+mirtazapine
RxNorm normalized name: venlafaxine Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: venlafaxine-extended-release+mirtazapine
Trial: 23192403
Drug: Operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Operative treatment (nonobese)
Trial: 23192403
Drug: Operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Operative treatment (obese)
Trial: 23192403
Drug: Nonoperative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonoperative treatment (nonobese)
Trial: 23192403
Drug: Nonoperative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonoperative treatment (obese)
Trial: 23192403
Drug: Operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Operative treatment (both groups)
Trial: 12857467
Drug: L-Arginine (L-Arg)
RxNorm normalized name: L-Arg
DrugBank: L-arginine (DB17289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-Arginine (L-Arg) treatment
Trial: 10365899
Drug: Pyloriset EIA‐G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyloriset EIA‐G New (a quantitative enzyme‐linked immunosorbent assay)
Trial: 8983917
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of acute exercise (E) + endurance training (T)
Trial: 8983917
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of acute exercise (E) + endurance training (T) + selenium supplementation (Sel)
Trial: 6294793
Drug: Cefotaxime (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime (2 g daily for 5-10 days, max 12 g in severe cases)
Trial: 6294793
Drug: Cefotaxime (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime (2 g daily for 5-10 days)
Trial: 6294793
Drug: Cefazolin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin (2 g daily for 5-10 days)
Trial: 25622882
Drug: Intra-alveolar chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-alveolar chlorhexidine (CHX) gel
Trial: 23250911
Drug: Adaptive servo-ventilation
RxNorm normalized name: Servo Stat Bac
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adaptive servo-ventilation (ASV) combined with medications
Trial: 10755201
Drug: Quinapril (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril (40 mg)
Trial: 10755201
Drug: Captopril (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (3 x 50 mg)
Trial: 2021872
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone dipropionate (BDP) for 6 weeks
Trial: 31338790
Drug: Cognitive intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive intervention (Michael's game) alongside standard treatment for psychosis
Trial: 31338790
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment for psychosis
Trial: 25134001
Drug: Glucose-fructose beverage
RxNorm normalized name: fructose / glucose / phosphoric acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose-fructose beverage (1.55 g·min, 2:1 ratio)
Trial: 25134001
Drug: Moderate-glucose beverage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-glucose beverage (1.03 g·min)
Trial: 25134001
Drug: High-glucose beverage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-glucose beverage (1.55 g·min)
Trial: 15665657
Drug: Soy isoflavone
RxNorm normalized name: soy isoflavone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy isoflavone supplementation (110 mg/day)
Trial: 10193289
Drug: Granisetron 3
RxNorm normalized name: granisetron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron 3 mg with Dexamethasone 8 mg
Trial: 8594966
Drug: Lidocaine (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (6 mg/kg body weight)
Trial: 8594966
Drug: Prilocaine (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prilocaine (7 mg/kg body weight)
Trial: 702289
Drug: Suspension A
RxNorm normalized name: KIT, SUSPENSION AND CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suspension A
Trial: 702289
Drug: Suspension B
RxNorm normalized name: DROPS, SUSPENSION BIPHASIC RELEASE (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suspension B (Control)
Trial: 28007717
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of PUFA twice daily
Trial: 21509675
Drug: Lamivudine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamivudine (100 mg per day) combined with Chinese medicine (CM) treatment for 12 weeks
Trial: 21509675
Drug: Lamivudine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamivudine (100 mg per day) alone for 12 weeks
Trial: 19538406
Drug: Natural childbirth
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natural childbirth preparation with psychoprophylactic training (breathing and relaxation techniques)
Trial: 19538406
Drug: Natural childbirth
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natural childbirth preparation with psychoprophylactic training
Trial: 9322446
Drug: Enoximone (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoximone (0.25 mg/kg bolus, cumulative dose 0.5 mg/kg)
Trial: 8227480
Drug: Trandolapril 1
RxNorm normalized name: trandolapril 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trandolapril 1 mg once daily
Trial: 8227480
Drug: Trandolapril 0.5
RxNorm normalized name: trandolapril 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trandolapril 0.5 mg twice daily
Trial: 3510525
Drug: Diltiazem-SR 240
RxNorm normalized name: diltiazem hydrochloride 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem-SR 240 mg/day
Trial: 3510525
Drug: Diltiazem-SR 360
RxNorm normalized name: diltiazem hydrochloride 360 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem-SR 360 mg/day
Trial: 27344296
Drug: Radium-223 (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radium-223 (50 kBq/kg, intravenous injection) every 4 weeks for six cycles
Trial: 24009292
Drug: Divided dosing
RxNorm normalized name: Aluminum Zirconium Trichlorohydrex Gly 20 g in 100 g TOPICAL STICK [Dividends]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Divided dosing (BD) prednisolone
Trial: 20211573
Drug: Sub-Tenon's ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sub-Tenon's ropivacaine 1% (2.5-3 mL)
Trial: 20211573
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution (2.5-3 mL) in the control group
Trial: 15715614
Drug: 5 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml/kg of Ringer's acetate over 3 min
Trial: 15715614
Drug: 2 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 ml/kg of low‐molecular weight (1 kDa) dextran over 3 min
Trial: 15715614
Drug: 15 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 ml/kg of Ringer's acetate over 40 min
Trial: 11844036
Drug: Intra-articular hyaluronic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular hyaluronic acid (HA) treatment
Trial: 7582386
Drug: Simvastatin 10‐40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 10‐40 mg once a day
Trial: 2311339
Drug: Perindopril (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (4 mg administered orally) with food
Trial: 30118728
Drug: Supervised therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised therapy with mometasone furoate (80% of students prescribed)
Trial: 29437071
Drug: Three-monthly follow-up
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-monthly follow-up group
Trial: 29437071
Drug: Six-monthly follow-up
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Six-monthly follow-up group
Trial: 23173251
Drug: Danlou tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danlou tablet (DT) + Western medicine
Trial: 23173251
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine (Control)
Trial: 18020073
Drug: 60 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg/kg paracetamol
Trial: 18020073
Drug: 90 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 mg/kg paracetamol
Trial: 15960557
Drug: Salmeterol/fluticasone propionate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol/fluticasone propionate 50/500 microg twice daily
Trial: 10660874
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg ENDUROX
Trial: 10660874
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg placebo
Trial: 373425
Drug: BCG treatment
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG treatment (5 patients)
Trial: 373425
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (4 patients)
Trial: 31494943
Drug: Left ventricular
RxNorm normalized name: DRESSING,VENTRICULAR ASSIST DEVICE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Left ventricular assist device (LVAD) therapy
Trial: 27647855
Drug: TGF‐beta1 mAb
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TGF‐beta1 mAb (2‐, 10‐, or 50‐mg monthly subcutaneous dosing for 12 months)
Trial: 25010820
Drug: Hemodynamic protocol
RxNorm normalized name: Olay Professional Acne Protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hemodynamic protocol including fluid administration and vasoactive drugs based on arterial blood pressure, cardiac index, and stroke volume response
Trial: 19143532
Drug: Ribavirin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ribavirin (10 mg/kg per day in 4 divided doses for 7 days)
Trial: 9240884
Drug: Bolus delivery
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus delivery of Curosurf (200 mg kg(‐1))
Trial: 9240884
Drug: Side-hole delivery
RxNorm normalized name: cured fat, pork side bacon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Side-hole delivery of Curosurf (200 mg kg(‐1))
Trial: 8275903
Drug: Naltrexone 1
RxNorm normalized name: NALTREXONE 1.5MG CAP,ORAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 1 mg/kg/day
Trial: 8275903
Drug: Naltrexone 0.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 0.5, 1, and 2 mg/kg/day
Trial: 3122164
Drug: Thyrotropin‐releasing hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyrotropin‐releasing hormone (TRH) administered intravenously
Trial: 31273577
Drug: EGFR antibody-drug
RxNorm normalized name: digoxin antibodies Fab fragments
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EGFR antibody-drug conjugate (specific dosage and duration not mentioned)
Trial: 22167145
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of antidepressants (SSRIs) and cognitive behavioral therapy (CBT) for 6 weeks
Trial: 22167145
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of antidepressants (SSRIs) and cognitive behavioral therapy (CBT)
Trial: 19780375
Drug: High-intensity respiratory
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-intensity respiratory muscle training (RMT) performed daily at approximately 90% PI(max) for 6 weeks with 2 x 30 breath cycles using an Ultrabreathe lung trainer
Trial: 15810603
Drug: Zhuyutongmai (ZYTM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zhuyutongmai (ZYTM) Capsule
Trial: 11522557
Drug: Calcium load
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium load of 0 and 25 mg/kg body weight taken at 0900 and 2100
Trial: 11522557
Drug: Calcium load
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium load of 0, 250, and 1000 mg taken at 0900
Trial: 11522557
Drug: Calcium load
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium load of 0 and 200 mg taken 4 times/day
Trial: 11522557
Drug: Calcium loads
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium loads of 0, 250, 1000 mg, and 200 mg taken at various times
Trial: 1358168
Drug: High-dose oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose oral tamoxifen (480 or 720 mg day‐1 for 6 days beginning 3 days before etoposide)
Trial: 1358168
Drug: Oral etoposide
RxNorm normalized name: Etoposide
DrugBank: Etoposide (DB00773)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral etoposide (300 mg day‐1 for 3 days)
Trial: 1358168
Drug: High-dose oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose oral tamoxifen
Trial: 6585909
Drug: Oxygen releasing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen releasing agent (two or four times a day for 1 week)